Literature DB >> 22383731

A case report of expanded-spectrum beta-lactamase-producing Klebsiella pneumoniae peritonitis in a patient on continuous ambulatory peritoneal dialysis.

A Sandhu, S Zheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383731      PMCID: PMC3525410          DOI: 10.3747/pdi.2011.00108

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

3.  Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients.

Authors:  Terence Yip; Kai-Chung Tse; Man-Fai Lam; Sydney Tang; Fu-Keung Li; Bo-Ying Choy; Sing-Leung Lui; Tak-Mao Chan; Kar-Neng Lai; Wai-Kei Lo
Journal:  Perit Dial Int       Date:  2006 Mar-Apr       Impact factor: 1.756

4.  Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis.

Authors:  Chih-Chao Yang; Feng-Rong Chuang; Kuo-Tai Hsu; Jin-Bor Chen; Chih-Hsiung Lee; Chie-Te Lee; Yu-Shu Chien; Te-Chuan Chen; Ben-Chung Cheng
Journal:  Am J Kidney Dis       Date:  2004-12       Impact factor: 8.860

5.  Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki Deok Lee; Hong Bin Kim; Myoung-Don Oh; Eui-Chong Kim; Hyo-Suk Lee; Kang Won Choe
Journal:  Korean J Intern Med       Date:  2004-09       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.